1. Home
  2. People
  3. Sherer, Jeremy

Jeremy D. Sherer

Partner

Boston

Jeremy provides business-oriented guidance to help those reshaping the U.S. health care industry.  

A partner in the firm's Chambers-ranked healthcare practice, Jeremy serves as a strategic advisor and "product counsel" to  digital health, health tech, and healthcare companies – from seed stage startups to national health systems and publicly traded companies – focusing on regulatory compliance, transactions and innovative business arrangements.

Jeremy advises clients on the full range of regulatory health care issues facing digital health stakeholders. His depth and breadth of experience enables him to help established and early-stage companies navigate a complex and ever-changing business and regulatory landscape. As one client’s CEO explained, “Jeremy is one of the best thought partners, and hands down the best legal navigator, I’ve found in the digital health space.”

His telehealth experience includes advising on compliance with state licensure requirements for physicians and non-physician practitioners, corporate practice of medicine issues, remote prescribing (including controlled substances), patient consent and Medicare, Medicaid and commercial reimbursement. He advises clients on compliance with laws against fraud and abuse, including federal and state anti-kickback and self-referral laws, as well as privacy issues arising under HIPAA and its state-level counterparts.

Jeremy has substantial experience pertaining to structuring, operationalizing and scaling “PC-MSO” arrangements across all 50 states. He also advises venture capital and private equity firms conducting regulatory diligence associated with investments in digital health and health care technology ventures, from seed stage funding to nine-figure raises.

“Jeremy is amazing in the digital health space ... what makes him so amazing is he's just continuously intellectually curious." -Chambers USA, Healthcare, 2025

    • Guided dozens of digital health companies through building and scaling “PC-MSO" arrangements across all 50 states.
    • Counseled national telebehavioral health platform on prescription of controlled substances, in order to comply with the Ryan Haight Act and state law.
    • Advised 100+ digital health companies on developing and implementing robust regulatory compliance programs addressing issues that involved professional licensure, scope of practice, supervision, prescribing practices and patient consent.
    • Performed healthcare regulatory diligence on behalf of venture capital firm in $200 million Series D investment in innovative telehealth platform.
    • Guided venture-backed pediatric care provider through $20 million Series B financing as regulatory counsel and in subsequent practice acquisitions to expand into additional states.
    • Served as regulatory counsel to industry-leading artificial intelligence “symptom checker” solution, including structuring “per-click” compensation arrangements to comply with applicable law and HHS-OIG guidance.
    • Developed frameworks for publicly traded telehealth platform client addressing non-physician practitioner supervision and proxy credentialing issues nationwide.
    • Represented nationally recognized pediatric health system in establishing national telehealth practice, including advising on licensure, prescribing, consent and corporate practice of medicine issues across all 50 states.

Insights

Events

News